Companies · Other Health Care

Arrayent Health, LLC

STAMFORD · Other Health Care

Diligence memoA one-page analyst read on Arrayent Health, LLC — recommendation, valuation, rhythm, risks.
$2.0M
Total raised · real
4
Rounds
0.8×
Latest step-up
Top 55%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time)

Arrayent Health, LLC looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.23× the median modeled value of Pre-Seed Other Health Care companies in 2013–2015 (343 peers) — value vs value, same stage and era.
  • Within the normal band (123% of peer median) for its niche.
Dormant
  • Last raise 12.2 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Arrayent Health, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
14.5 yr record
Peak capital year was 2012 with $950K across 2 filings.
Market position
ahead of 46% of Other Health Care peers
Capital scale is ahead of 46% of Other Health Care peers; modeled value is above 38% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2012: $950K across 2 filings.
  • Largest single filing was $558K on 2011-12-30.
  • Filing rows sum to $2.4M, while canonical raised total is $2.0M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Arrayent Health, LLC is one of 5376 Other Health Care companies tracked from STAMFORD. By capital raised it ranks mid-pack (ahead of 46% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$5.0M$10M$15M$20MPre-Seed · 2011-12-30 Raised $558K (real) Modeled valuation $17M (est)$558K$17MPre-Seed2011Pre-Seed · 2012-07-24 Raised $475K (real) Modeled valuation $15M (est)$475K$15MPre-Seed2012Pre-Seed · 2012-07-24 Raised $475K (real) Modeled valuation $15M (est)$475K$15MPre-Seed2012Pre-Seed · 2013-07-26 Raised $525K (real) Modeled valuation $16M (est)$525K$16MPre-Seed2013Pre-Seed · 2014-04-08 Raised $400K (real) Modeled valuation $12M (est)$400K$12MPre-Seed2014+$475K+$475K+$525K+$400KCumulative $2.4M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$558K · 2011
Pre-Seed extension$475K · 2012
Pre-Seed extension$475K · 2012
Pre-Seed extension$525K · 2013
Pre-Seed extension$400K · 2014

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$12.3M
Base estimate est.
$251K
Conservative case
$139.8M
Upside case
$2.2M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $17.2M · 2011-12-302011Pre-Seed · modeled $14.6M · 2012-07-24Pre-Seed · modeled $14.6M · 2012-07-24Pre-Seed · modeled $16.2M · 2013-07-26Pre-Seed · modeled $12.3M · 2014-04-082014
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
28%
Survival probability
11% low · 52% high
1.64×/yr
Annual markup
2.23×/yr upside case
6.0 yr
Elapsed time used
12.2 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
7 mo
Avg between rounds
$862K/yr
Capital velocity
14.5 yr
On record since
2011
First round
5
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.8× of median
This company$2.0M
Sector median$2.4M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 1.1× above median
This company$400K
Sector median$350K
Modeled value — vs sector median (estimate, all stages) 0.6× of median
This company$12.3M
Sector median$22.1M

Raised more than 46% of sector peers (real $). Modeled value above 38% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #139 of 343.

This companyCohort peer
$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)Optimized Care Network, LLC · Pre-Seed Raised $1.0M · modeled $30.8M (est)Sensiotec Inc. · Pre-Seed Raised $1.0M · modeled $30.8M (est)In2Bones Usa, Llc · Pre-Seed Raised $1.0M · modeled $30.8M (est)Medinvus, LLC · Pre-Seed Raised $1.0M · modeled $30.8M (est)ERG Holding Company, LLC · Pre-Seed Raised $1.0M · modeled $30.8M (est)Phoenix Clinical Inc. · Pre-Seed Raised $1.0M · modeled $30.8M (est)Versaworks, Inc. · Pre-Seed Raised $1.0M · modeled $30.8M (est)Nath Holdings, LLC · Pre-Seed Raised $1.0M · modeled $30.8M (est)PSI Premier Specialties, Inc. · Pre-Seed Raised $1.0M · modeled $30.8M (est)SKYMEDICUS, Inc. · Pre-Seed Raised $1.0M · modeled $30.8M (est)Pure Life Renal LLC · Pre-Seed Raised $1.5M · modeled $30.8M (est)Ludi, Inc. · Pre-Seed Raised $1.0M · modeled $30.8M (est)Arrayent Health, LLC (this company) Raised $2.0M · modeled $12.3M (est)Arrayent Health, LLC
CompanyStageRaised · realValue · estvs peer med.
Optimized Care Network, LLCPre-Seed$1.0M$30.8M3.08×
Sensiotec Inc.Pre-Seed$1.0M$30.8M3.08×
In2Bones Usa, LlcPre-Seed$1.0M$30.8M3.08×
Medinvus, LLCPre-Seed$1.0M$30.8M3.08×
ERG Holding Company, LLCPre-Seed$1.0M$30.8M3.08×
Phoenix Clinical Inc.Pre-Seed$1.0M$30.8M3.08×
Versaworks, Inc.Pre-Seed$1.0M$30.8M3.08×
Nath Holdings, LLCPre-Seed$1.0M$30.8M3.08×
PSI Premier Specialties, Inc.Pre-Seed$1.0M$30.8M3.08×
SKYMEDICUS, Inc.Pre-Seed$1.0M$30.8M3.08×
Pure Life Renal LLCPre-Seed$1.5M$30.8M3.08×
Ludi, Inc.Pre-Seed$1.0M$30.8M3.08×
Arrayent Health, LLC this companyPre-Seed$2.0M$12.3M1.23×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$558K2011-12-30$3.1M$17.2M90%
Pre-Seed$475K2012-07-24$2.6M$14.6M90%
Pre-Seed$475K2012-07-24$2.6M$14.6M90%
Pre-Seed$525K2013-07-26$2.9M$16.2M90%
Pre-Seed$400K2014-04-08$2.2M$12.3M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$558K2011-12-30
    • First recorded raise — entered as Pre-Seed.
  2. Pre-Seed$475K2012-07-24
    • Came back fast: 7 mo vs the ~14 mo sector norm.
    • Round roughly the size of the prior one.
  3. Pre-Seed$475K2012-07-24
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  4. Pre-Seed$525K2013-07-26
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
  5. Pre-Seed$400K2014-04-08
    • Raised 8 mo later, in step with the ~14 mo sector norm.
    • Round 1.3× smaller than the prior — bridge or down round.
Intelligence
2014 ~Q4
Modeled next raise · ~7mo cadence
$400K
Modeled next size est.range $400K$640K
0.8×
Last step-up
$862K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Alden R Stevens2011-12
Kevin R Jones2011-12
Robert R D'Alessandro2011-12
Registry & provenance

Arrayent Health, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1538930
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
JDCQ Solutions, LLCOther Health CarePre-Seed$1.9M$12.3Msame sector · same stage
American Nitrile Intermediate Holdings, LLCOther Health CarePre-Seed$1.8M$10.4Msame sector · same stage
Pinnacle Integrated Medicine, Inc.Other Health CarePre-Seed$2.3M$12.3Msame sector · same stage
Streamline, Inc.Other Health CarePre-Seed$1.5M$14.7Msame sector · same stage
NuvoMed, Inc.Other Health CarePre-Seed$1.4M$12.0Msame sector · same stage
Castlewood Surgical IncOther Health CarePre-Seed$1.4M$12.6Msame sector · same stage
Phyto Management LLCOther Health CarePre-Seed$1.4M$13.9Msame sector · same stage
Patient Conversation Media, Inc.Other Health CarePre-Seed$1.3M$10.8Msame sector · same stage
Frequently asked
How much funding has Arrayent Health, LLC raised?
Arrayent Health, LLC has raised approximately $2.0M in disclosed capital across 4 recorded financing rounds, aggregated from public filings.
What is Arrayent Health, LLC's estimated valuation?
Provath's modeled valuation for Arrayent Health, LLC is approximately $12.3M (modeled range $251K–$139.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Arrayent Health, LLC at?
Arrayent Health, LLC's latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Tue Apr 08.
What does Arrayent Health, LLC do and where is it based?
Arrayent Health, LLC operates in the Other Health Care sector, based in STAMFORD.
Explore related

See where Arrayent Health, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Arrayent Health, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.